Alphatec FY2025 revenue $764M (+25% YoY); guides FY2026 ~$890M, raises EBITDA guidance

Alphatec Holdings, Inc.

2025-FY EPS reported -$0.96 revenue$764,155,000

Full-year 2025 total revenue $764M (+25% YoY); GAAP net loss $143M; non-GAAP net income $8M.
Q4 2025 revenue $213M; adjusted EBITDA $33M (16% margin), expanding 390 bps YoY; positive Q4 free cash flow $8M.
FY2026 guidance: revenue ~$890M (+17%); adj. EBITDA ~$134M (15% of rev, up from $130M); FCF >=$20M.
Surgical revenue $190M in Q4 (+21% YoY); net new surgeon users +23% in Q4, +20% full year.
Valence intraoperative platform cleared and released; EOS Insight proliferation noted.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.